NVNO
enVVeno Medical Corp
8.40$
+2.4%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,206.63 | – | 2,195.28 | 1,335.79 | 609.65 | 60.67 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 1,359.40 | 350.34 | 2,685.66 | 1,768.58 | 0.00 | – | 364.30 | 63.92 | 57.27 | 54.37 | 37.73 | 0.83 | |
| -152.77 | -350.34 | -490.38 | -432.79 | 609.65 | 60.67 | -364.30 | -63.92 | -57.27 | -54.37 | -37.73 | -0.83 | |
| – | – | – | 2,056.13 | 4,048.20 | 4,283.73 | 4,034.39 | 808.30 | 1,081.49 | 1,352.62 | 875.37 | 16.95 | |
| – | – | – | 17,265.71 | 21,186.12 | 9,537.11 | 4,632.71 | 1,575.62 | 1,638.27 | 1,197.07 | 827.34 | 18.54 | |
| 4,707.74 | 3,252.59 | 12,524.10 | 18,881.28 | 26,278.88 | 14,964.18 | 8,302.80 | 2,320.01 | 2,662.49 | 2,458.87 | 1,664.98 | 35.48 | |
| -4,860.51 | -3,602.94 | -13,014.48 | -19,314.07 | -25,669.23 | -14,903.52 | -8,667.10 | -2,383.93 | -2,719.76 | -2,513.24 | -1,702.71 | -35.48 | |
| 334.14 | 247.27 | 161.70 | 6,074.80 | 22,421.23 | 1.81 | 3.55 | 2.64 | 28.69 | – | – | – | |
| -5,194.65 | -3,849.72 | -15,609.66 | -24,656.55 | -42,623.23 | -14,806.60 | -8,667.44 | -2,332.46 | -2,691.07 | -2,341.76 | -1,559.28 | -33.06 | |
| – | 878.04 | -5,985.69 | 662.99 | 5,467.23 | 1,676.78 | -204.50 | -46.77 | -39.82 | – | – | – | |
| -7,132.62 | -4,480.48 | -16,442.86 | -24,656.55 | -42,623.23 | -14,806.60 | -8,667.44 | -2,332.46 | -2,691.07 | -2,341.76 | -1,559.28 | -33.06 | |
| -4,176.18 | -3,252.10 | -15,025.68 | -18,141.20 | -19,765.99 | -14,034.56 | -8,303.15 | -2,268.55 | -2,633.80 | -2,287.39 | -1,521.55 | -32.23 |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.